Thursday, February 13, 2020 5:59:42 PM
flipper44,
The ASM has been pushed out for several years in my opinion as a strategic move towards a planned shorter, tighter and hard hitting news cycle leading up to approval. There are multiple hints that this will happen. Even you have said that NWBO runs on it's own time line so this delay in the ASM should not come as a big surprise. The draft SAP is done which means there has been a probable comment period of at least 60 days once that was done. The combo trial is up and running. The Direct Phase 1 safety trial results are almost 6 years old for a few patients. L trial data is essentially set in stone for 5 years. The data from the pseudo patient trial is also very mature but won't be mentioned much unless it gets added into Phase 3 data and that was set to happen only if PFS was statistically significant so mum's the word until that is verified. Commercial scale up is ready to happen in the US and should be ready by year end in the UK. Lot's of news that many folks are not aware of and assuming top line and an abstract or other presentation is in the works the ASM should have some substance this time around. In just over 3 weeks any investor can ask a judge in the right juristiction to set a date for an ASM and force the company to hold one. Linda knows this and she likes things done on her terms. Best wishes.
The ASM has been pushed out for several years in my opinion as a strategic move towards a planned shorter, tighter and hard hitting news cycle leading up to approval. There are multiple hints that this will happen. Even you have said that NWBO runs on it's own time line so this delay in the ASM should not come as a big surprise. The draft SAP is done which means there has been a probable comment period of at least 60 days once that was done. The combo trial is up and running. The Direct Phase 1 safety trial results are almost 6 years old for a few patients. L trial data is essentially set in stone for 5 years. The data from the pseudo patient trial is also very mature but won't be mentioned much unless it gets added into Phase 3 data and that was set to happen only if PFS was statistically significant so mum's the word until that is verified. Commercial scale up is ready to happen in the US and should be ready by year end in the UK. Lot's of news that many folks are not aware of and assuming top line and an abstract or other presentation is in the works the ASM should have some substance this time around. In just over 3 weeks any investor can ask a judge in the right juristiction to set a date for an ASM and force the company to hold one. Linda knows this and she likes things done on her terms. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
